Picture of Zhaoke Ophthalmology logo

6622 — Zhaoke Ophthalmology News Story

0.000.00%
hk flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapSucker Stock

Brief: Zhaoke Ophthalmology Says Ophth-B Atropine Sulfate Eye Drops Application Accepted For Evaluation By Australia's TGA

BRIEF-Zhaoke Ophthalmology Says Ophth-B Atropine Sulfate Eye Drops Application Accepted For Evaluation By Australia's TGA

- Zhaoke Ophthalmology Ltd 6622.HK:

  • OPHTH-B ATROPINE SULFATE EYE DROPS APPLICATION ACCEPTED FOR EVALUATION BY AUSTRALIA'S TGA


Further company coverage: 6622.HK


((Reuters.Briefs@thomsonreuters.com;))

Recent news on Zhaoke Ophthalmology

See all news